Ethanol → HCID 20562369, compound
Reaction equation
[NH2:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]([CH3:12])[C:10](=[O:13])[CH2:9][N:8]=[C:7]([C:14]3[CH:19]=[CH:18][CH:17]=[CH:16][C:15]=3[F:20])[C:6]=2[C:21]=1[Cl:22].[Cl:23][CH2:24][CH2:25][N:26]=[C:27]=[O:28].C(N(CC)CC)C.C(O)C>O1CCCC1>[Cl:23][CH2:24][CH2:25][NH:26][C:27]([NH:1][C:2]1[CH:3]=[CH:4][C:5]2[N:11]([CH3:12])[C:10](=[O:13])[CH2:9][N:8]=[C:7]([C:14]3[CH:19]=[CH:18][CH:17]=[CH:16][C:15]=3[F:20])[C:6]=2[C:21]=1[Cl:22])=[O:28]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
5 g (0.016 M) of 7-amino-6-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one in 85 ml of absolute tetrahydrofuran are treated with 11.1 ml of chloroethylisocyanate and 1 ml of triethylamine. The mixture is stirred at room temperature for 1 week and heated at reflux for 5 hours. The mixture is treated with 50 ml of ethanol and concentrated. The residue is treated with methylene chloride/water and extracted several times with methylene chloride. The organic phase is separated, dried with sodium sulphate, filtered and concentrated. The residue is purified on a 300 g silica gel column using methylene chloride/ethyl acetate (3:1) as the eluting agent, there being obtained 1-(2-chloroethyl)-3-[6-chloro-5-(o-fluorophenyl)-2,3-dihydro-1-methyl-2-oxo-1H-1,4-benzodiazepin-7-yl]urea which is further processed directly.
Workup
- temperatureheated
- temperatureat reflux for 5 hours
- concentrationconcentrated
- additionThe residue is treated with methylene chloride/water
- extractionextracted several times with methylene chloride
- customThe organic phase is separated
- dry with materialdried with sodium sulphate
- filtrationfiltered
- concentrationconcentrated
- customThe residue is purified on a 300 g silica gel column
Sources & evidence
- ORD record
- ord-4b1f2ff5836e4917823d0adbc894f346
- Source dataset
- uspto-grants-1981_10
- Patent number
- US04296031
Reaction notes
Loading…